124 STAT. 692 PUBLIC LAW 111–148—MAR. 23, 2010 ‘‘(A) ESTABLISHMENT.—Not later than October 1, 2011, the Secretary shall establish procedures— ‘‘(i) for applicable manufacturers and applicable group purchasing organizations to submit information to the Secretary under subsection (a); and ‘‘(ii) for the Secretary to make such information submitted available to the public. ‘‘(B) DEFINITION OF TERMS.—The procedures estab- lished under subparagraph (A) shall provide for the defini- tion of terms (other than those terms defined in subsection (e)), as appropriate, for purposes of this section. ‘‘(C) PUBLIC AVAILABILITY.—Except as provided in subparagraph (E), the procedures established under subparagraph (A)(ii) shall ensure that, not later than Sep- tember 30, 2013, and on June 30 of each calendar year beginning thereafter, the information submitted under sub- section (a) with respect to the preceding calendar year is made available through an Internet website that— ‘‘(i) is searchable and is in a format that is clear and understandable; ‘‘(ii) contains information that is presented by the name of the applicable manufacturer or applicable group purchasing organization, the name of the covered recipient, the business address of the covered recipient, the specialty of the covered recipient, the value of the payment or other transfer of value, the date on which the payment or other transfer of value was provided to the covered recipient, the form of the pay- ment or other transfer of value, indicated (as appro- priate) under subsection (a)(1)(A)(v), the nature of the payment or other transfer of value, indicated (as appro- priate) under subsection (a)(1)(A)(vi), and the name of the covered drug, device, biological, or medical supply, as applicable; ‘‘(iii) contains information that is able to be easily aggregated and downloaded; ‘‘(iv) contains a description of any enforcement actions taken to carry out this section, including any penalties imposed under subsection (b), during the pre- ceding year; ‘‘(v) contains background information on industry- physician relationships; ‘‘(vi) in the case of information submitted with respect to a payment or other transfer of value described in subparagraph (E)(i), lists such information separately from the other information submitted under subsection (a) and designates such separately listed information as funding for clinical research; ‘‘(vii) contains any other information the Secretary determines would be helpful to the average consumer; ‘‘(viii) does not contain the National Provider Identifier of the covered recipient, and ‘‘(ix) subject to subparagraph (D), provides the applicable manufacturer, applicable group purchasing organization, or covered recipient an opportunity to review and submit corrections to the information sub- mitted with respect to the applicable manufacturer, Deadlines. Web posting. Deadline.
